Ending the transmission of HBV from the perinatal period throughout the lifespan (abbreviated as “END B”)

Summary

The END B intervention was designed to prevent chronic Hepatitis B (HBV) transmission and improve health outcomes among Asian populations (age 1-18+), focusing on addressing health disparities. The intervention enhanced HBV screening and prevention through in-person education sessions, culturally tailored materials (e.g., brochures and PowerPoints), and patient navigator follow-ups. The intervention increased HBV screening rates and improved knowledge among participants, and its effectiveness was highlighted in three PubMed-indexed publications.

Overview

Purpose of Intervention:

The purpose of the END B intervention is to spare the next generation of Sacramento patients enrolled in the Health and Life Organization (HALO) from preventable hepatitis B infection.

Intervention Type:

Advanced — Pilot, demonstration or feasibility interventions with adequate methodological rigor that have demonstrated short-term or long-term positive effects on one or more targeted outcomes to improve minority health and/or health disparities through quantitative measures; Studies have a comparison group and are published in a peer-review journal.

Intervention Details

Intervention was Primarily Driven, Led, or Managed by:

Academic/Clinical Researchers Only

Citations:

Chak E, Vu F, Dang J, Smith U, Stewart S, Tam K, Beste-Fong A, Phelps B, Johnson I, Suarez M, Pat Pauly M, Chen MS Jr. Enhancing Electronic Health Systems to End Transmission of Chronic Hepatitis B During COVID-19: A Collaborative Approach. Clin Liver Dis (Hoboken). 2021 Aug 5;17(6):424-428. doi: 10.1002/cld.1144. PMID: 34386208; PMCID: PMC8340353. Link
Relevance: Main Intervention, Post-Intervention Outcomes
Chak E, Taefi A, Li CS, Chen MS Jr, Harris AM, MacDonald S, Bowlus C. Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial. Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1352-1357. doi: 10.1158/1055-9965.EPI-18-0448. Epub 2018 Aug 8. PMID: 30089680; PMCID: PMC6214733. Link
Relevance: Evaluations and Assessments
Chak EW, Luna R, MacDonald S, Stewart SL, Chen MS Jr, Bowlus C. Automated electronic health registry-based hepatitis B screening. J Viral Hepat. 2023 Mar;30(3):228-231. doi: 10.1111/jvh.13784. Epub 2022 Dec 21. PMID: 36514989; PMCID: PMC10803191. Link
Relevance: Evaluations and Assessments

Adaptation of Another Research-based Intervention:

Yes

Name of Original Intervention:

Perinatal HBV transmission prevention/screening and referral to hepatologist or primary care provider for interpretation of screening tests.

URL to original Intervention:

n/a

Citations:

U.S. Preventive Services Task Force. Hepatitis B Virus Infection in Adolescents and Adults: Screening. JAMA. 2020;324(23):2415-2422. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening. Accessed August 21, 2024. Link

Intervention Primary Outcomes were comparable to the original:

Yes

Contact Information

Primary Contact Affiliation:

Office of Community Outreach and Engagement, UC Davis Comprehensive Cancer Center, Sacramento, CA

Intervention URL:

Not available

Results

Intentions

Improve minority health or the health of other populations with health disparities (e.g. rural populations, populations with low SES)

Intervention Primary Outcome:

Prevention perinatal HBV transmission

Intervention Secondary Outcome:

Increase screening for HBV

Key Findings:

As a result of early adoption of telehealth services at HALO during the COVID-19 pandemic, completion of HBV testing among pregnant women at HALO remained only slightly below prepandemic levels. Use of an EHR‐based registry of high‐risk patients across all HALO clinics led to a large increase in the number of tests completed and new HBV cases detected. For example, 19 new HBV diagnoses were found within 6 months of use compared with 3 in the 6 months prior to initiating registry‐based testing. All of these patients were linked to the care of a hepatologist.

Statistical Method Used:

Descriptive statistics

Was statistical method used to analyze data from original Intervention comparable to the original:

Yes

Demographic and Implementation Description

Diseases, Disorders, or Conditions:

Hepatitis B

Race/Ethnicity:

Asian

Populations with Health Disparities:

People with Lower Socioeconomic Status (SES), Racial and Ethnic Minority Populations

Age:

Young Adults (18 - 39 years), Middle-Aged Adults (40 - 64 years), Older Adults (65+ years)

Characteristics and Implementation

Intervention Focus Area:

Behavior Change

Disease Continuum:

Secondary Prevention

Delivery Setting:

Clinic / Health Care Facility

Mode of Delivery:

In-person

Who delivered the Intervention?:

Healthcare Professional (Physician, Nurse, Technician)

Adaptations and Modifications

Were modifications made?

Intervention Elements	Modified
Content	No
Context	No
Implementation	No
Funding	No
Organization	No
Participants	No
Providers	No
Sociopolitical	No
Stages of Occurrence	Yes

Impact, Lessons, Components

Produced an impact or change beyond the primary or secondary outcome:

Not Tested

Essential Aspects for Success:

Trust and leadership. Educational sessions, content, and materials on HBV were conducted/created in English and Hmong.

Products, Materials, and Funding

Expertise, Partnerships, and Funding Sources

	Used for Implementation	Needed for Sustainability
Expertise
Clinical Care	Yes	Yes
Partnerships
Universities	Yes	No
Funding Sources
Public funding (e.g., federal, state or local government)	Yes	Yes

Product/Material/Tools

	Tailored For Language	Language(s) if other than English	Material
Outreach/Recruitment Tools
Publicity Materials (e.g. Posters, Flyers, Press Releases)	Yes	Hmong	Attachment available for request at the bottom of the page.
How HALO staff can reduce the unique, unusual, but necessary cancer health disparities affecting Asian Americans PowerPoint	No		Attachment available for request at the bottom of the page.
Participant Educational Tools
HBV Patient Education Workshops PowerPoint - Hmong	Yes	Hmong	Attachment available for request at the bottom of the page.
HBV Patient Education Workshops PowerPoint - English	No		Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	No		Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	No		Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
Brochures/Factsheets/Pamphlets	Yes	Hmong	Attachment available for request at the bottom of the page.
MA Academy Training PowerPoint	No		Attachment available for request at the bottom of the page.
MA Academy Training PowerPoint	No		Attachment available for request at the bottom of the page.
MA Academy Training PowerPoint	No		Attachment available for request at the bottom of the page.
Measurement Tools
Non-Standardized Instruments/Surveys/Questionnaires	No		Attachment available for request at the bottom of the page.

Implementation Materials and Products

	Material
Implementation/Delivery Materials
Training/Operations manual	Attachment available for request at the bottom of the page.
Educational video for physicians/providers, and clinical staff	Attachment available for request at the bottom of the page.
HBV educational video for the public (#2)	Attachment available for request at the bottom of the page.
HBV educational video for the public (#3)	Attachment available for request at the bottom of the page.
HBV educational video for the public (#1)	https://youtu.be/5C8FWz3EFpY
Implementation/Output Materials
No Implementation/Output Materials provided.

Articles Related to Submitted Intervention

	Article
Reports/Monographs
No Reports/Monographs provided.
Additional Articles
No Additional Articles provided.

Materials Available for Request

Recruitment Poster Apr 10-17 Green Health Educational Workshop END B.pdf
6a. Cancer health disparities_MC (4.6.22) (1).pptx
Hmong HBV.pdf
English HBV.pdf
5a. Infographic Chronic Hepatitis B double-sided.pptx
5b. Infographic Chronic Hepatitis B Hmong double-sided.pptx
5c. Infographic General Screening double-sided.pptx
5d. Infographic General Screening Hmong double-sided.pptx
5e. Infographic General What to Do.pptx
5f. Infographic General What to Do Hmong.pptx
5g. Infographic prenatal (English).pptx
5h. Infographic prenatal (Hmong) (1).pptx
2019-06-15_Academy composite slides.pptx
2019-09-28_FINAL_HBV_MA_Slides .pptx
FINAL_Virtual HALO MA Academy.pptx
Feedback of HALO MA Academy - Survey Blank.docx
6c. Liver Cancer Module for MAs_Eric Chak.pptx
9a. END B - Hep B for Providers - produced by K. Simoes.mp4
9c. END B - Living with Chronic Hepatitis B - Video 2.mp4
9d. END B - Pregnancy, Hepatitis B and Moms - Video 3.mp4

Intervention IP-122: Ending the transmission of HBV from the perinatal period throughout the lifespan (abbreviated as “END B”)